MedTrace Logo

Post-hoc Analysis of Regional Pulmonary Perfusion and Hemodynamic Parameters Measured by Electrical Impedance Tomography

NCT04249414 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2023-03-06

No results posted yet for this study

Summary

Define the capability and reliability of the PulmoVista® 500 (PV500) to detect changes in global and regional ventilation and perfusion.

Conditions

  • Mechanical Ventilation
  • Ventilation Perfusion Mismatch

Interventions

DEVICE

PulmoVista 500

Monitoring of Ventilation and Perfusion with the PulmoVista 500 during clinical routine. No medical interventions required

Sponsors & Collaborators

  • University of Göttingen

    collaborator OTHER

  • Prof. Dr. med. Imhoff

    collaborator UNKNOWN

  • Drägerwerk AG & Co. KGaA

    lead INDUSTRY

Principal Investigators

  • Onnen Mörer, Prof. Dr. · Centre of Anaesthesiology University Medical Center Göttingen

  • Michael Quintel, Prof. Dr. · Centre of Anaesthesiology University Medical Center Göttingen

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04249414 on ClinicalTrials.gov